PuSH - Publication Server of Helmholtz Zentrum München

13 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Justice, A.E.* et al.: Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nat. Genet. 51, 452–469 (2019)
2.
Spracklen, C.N.* et al.: Exome-derived adiponectin-associated variants implicate obesity and lipid biology. Am. J. Hum. Genet. 105, 15-28 (2019)
3.
Turcot, V.* et al.: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (vol 50, pg 765, 2017). Nat. Genet. 50, 764-768 (2018)
4.
Liu, D.J.* et al.: Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758-1766 (2017)
5.
Marouli, E.* et al.: Rare and low-frequency coding variants alter human adult height. Nature 542, 186-190 (2017)
6.
Webb, T.R.* et al.: Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease. J. Am. Coll. Cardiol. 69, 823-836 (2017)
7.
de Vries, P.S.* et al.: A meta-analysis of 120,246 individuals identifies 18 new loci for fibrinogen concentration. Hum. Mol. Genet. 25, 358-370 (2016)
8.
Lessard, S.* et al.: Testing the role of predicted gene knockouts in human anthropometric trait variation. Hum. Mol. Genet. 25, 2082-2092 (2016)
9.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016)
10.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (vol 374, pg 1134, 2016). N. Engl. J. Med. 374, 1898-1898 (2016)
11.
Huffman, J.E.* et al.: Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood 126, e19-e29 (2015)
12.
TG and HDL Working Group (Crosby, J.R.* ; Peloso, G.M.* ; Auer, P.L.* ; Peters, A. ; Reiner, A.P.* ; Boerwinkle, E.* ; Kathiresan, S.*): Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014)
13.
Stitziel, N.O.* et al.: Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371, 2072-2082 (2014)